Theranostics in neurosurgery is a rapidly advancing field of precision medicine that combines diagnostic and therapeutic modalities to optimize patient outcomes. This approach has the potential to provide real-time feedback during therapy and diagnose a condition while simultaneously providing treatment. One such form of theranostics is focused ultrasound, which has been found to be effective in inducing neuroablation and neuromodulation and improving the efficacy of chemotherapy drugs by disrupting the blood-brain barrier. Targeted radionuclide therapy, which pairs positron emission tomography tracers with therapeutic effects and imaging modalities, is another promising form of theranostics for neurosurgery. Automated pathology analysis is yet another form of theranostics that can provide real-time feedback during the surgical resection of tumors. Electrical stimulation has also shown promise in optimizing therapies for patients with cerebral palsy. Overall, theranostics is a cost-effective way to optimize medical care for patients in neurosurgery. It is a relatively new field, but the advancements made so far show great promise for improving patient outcomes.
Keyphrases
- positron emission tomography
- cerebral palsy
- computed tomography
- end stage renal disease
- newly diagnosed
- ejection fraction
- high resolution
- machine learning
- spinal cord injury
- pet ct
- high throughput
- big data
- peritoneal dialysis
- squamous cell carcinoma
- pet imaging
- stem cells
- deep learning
- radiation therapy
- patient reported outcomes
- mass spectrometry
- risk assessment
- human health
- drug induced
- photodynamic therapy
- data analysis